There were no relationships noted between serum or CSF inflammatory markers and years with PD or disease severity or duration and CSF neurodegenerative markers (i.e., α-synuclein, Aβ40, and Aβ42; data not shown). This evidence concerns the gene SNCA and Parkinson disease.